Background: Insulin is classified as an "essential drug". It should be available in all pharmacies at an affordable price. This remains a major problem in low income countries like ours. Aim: Our study aims to describe the insulin availability and affordability in the Urban Municipality of Antananarivo, Madagascar. Methods: It was a cross sectional study over a period of 3 months at all pharmacies existing in the Urban Municipality of Antananarivo. Insulin availability was assessed according to the classification of the World Health Organization. Affordability was assessed from the ratio between the monthly cost of insulin treatment and the Malagasy monthly health expenditure, and the ratio between the monthly cost of insulin treatment and the guaranteed minimum inter-professional wage in Madagascar. Result: We had retained 79 pharmacies. Insulin availability in private pharmacies was higher than in public hospital pharmacies. Human insulin had a high availability rate: short-acting (70.89%) and mixed (78.08%). Availability of analogue insulin was low: fast-acting (7.59%) and long-acting (34.18%). To buy insulin, a patient was spending monthly 18.75 to 236.24% of the equivalent of guaranteed minimum inter-professional wage. All pharmacies had refrigerators to store insulin. Conclusion: The availability of insulin in the Urban Municipality of Antananarivo was high while diabetic patients have low financial affordability. A good governance health policy and multisectoral actions would be necessary.
| Published in | International Journal of Diabetes and Endocrinology (Volume 6, Issue 1) |
| DOI | 10.11648/j.ijde.20210601.11 |
| Page(s) | 1-4 |
| Creative Commons |
This is an Open Access article, distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution and reproduction in any medium or format, provided the original work is properly cited. |
| Copyright |
Copyright © The Author(s), 2021. Published by Science Publishing Group |
Affordability, Availability, Insulin, Madagascar
| [1] | Martín-Timón I, Sevillano-Collantes C, Segura-Galindo A, et al. Type 2 diabetes and cardiovascular disease: Have all risk factors the same strength? World J Diabetes. 2014; 5 (4): 444-70. |
| [2] | Charbonnel B, Penfornis A, Varroud-Vial M, Kusnik-Joinville O, Detournay B. Insulin therapy for diabetes mellitus: Treatment regimens and associated costs. Diabetes Metab. 2012; 38: 156–163. |
| [3] | Raherison RE, Ramilitiana B, Raharinavalona SA, Rakotomalala DP. New diabetics seen in Joseph Raseta Befelatanana Hospital of Antananarivo (2002-2003). Rev. méd. Madag. 2015; 5 (1): 526–30. |
| [4] | Ewen M, Joosse H-J, Beran D, et al. Insulin prices, availability and affordability in 13 low-income and middle-income countries. BMJ Global Health 2019; 4: e001410. |
| [5] | Ashcroft RE. Access to essential medicines: A hobbesian social contract approach. Dev World Bioeth. 2005; 5 (2): 121–41. |
| [6] | World Health Organization, Regional office for the Eastern Mediterranean. [Online]. Price, availability and affordability: an international comparison of chronic disease medicines. 2006. [Acces January 11, 2019]. Available on: http://apps.who.int/iris/handle/10665/116493. |
| [7] | World Health Organization, Health Action International. [Online]. Measuring medecine price, availability, affordability and price components. 2006; 2nd edition. 7. World Health Organization. [Acces January 11, 2019]. Available on: http://apps.who.int/iris/handle/10665/70013. |
| [8] | Liu C, Zhang X, Liu C, Ewen M, Zhang Z, Liu G. Insulin prices, availability and affordability: a cross-sectional survey of pharmacies in Hubei Province, China. BMC Health Serv Res. 2017; 17 (597): 1–9. |
| [9] | Madagascar Medicines Agency (AMM). List of pharmaceutical wholesalers [Online]. AMM; 2017. [Acces June 05, 2018]. Available on: http://www.agmed.mg/Pdf/Grossistes_Madagascar.pdf. |
| [10] | Sharma A, Kaplan WA. Challenges constraining access to insulin in the private-sector market of Delhi, India. BMJ Glob Heal. 2016; 1: 1–13. |
| [11] | Sanlioglu AD, Altunbas HA, Balci MK, Griffith TS, Sanlioglu S. Clinical utility of insulin and insulin analogs. Islets. 2013; 5 (2): 67–78. |
| [12] | Beran D, Ewen M, Laing R. Constraints and challenges in access to insulin: a global perspective. Lancet Diabetes Endocrinol. 2016; 4: 275–85. |
| [13] | Madagascar Medicines Agency (AMM). List of medicines registered in Madagascar by holders of A. M. M. [Online]. AMM; 2018. [Acces June 05, 2018]. Available on: http://www.agmed.mg/Pdf/Liste_AMM_Valid.pdf. |
| [14] | Beran D, Miranda JJ, Cardenas MK, Bigdeli M. Health systems research for policy change: lessons from the implementation of rapid assessment protocols for diabetes in low- and middle-income settings. Heal Res Policy Syst. 2015; 13 (41): 1–10. |
| [15] | Ministry of Public Health (MSANP). Country pharmaceutical profile. Madagascar: MSANP; 2011. |
| [16] | Beran D, Yudkin JS. Looking beyond the issue of access to insulin : What is needed for proper diabetes care in resource poor settings. Diabetes Res Clin Pract. 2010; 88 (3): 217–21. |
| [17] | Kaplan W. Insulin tarifs and taxes profile. Amsterdam: Health Action International; 2016. |
| [18] | Belghith NBH, Randriankolona PL, Osborne T. Madagascar Poverty and Inequality Update: Recent Trends in Welfare, Employment, and Vulnerability. International Bank for Reconstruction and Development/The World Bank. 2016. |
| [19] | Cefalu WT, Dawes DE, Gavlak G et al. Insulin Access and Affordability Working Group: Conclusions and Recommendations Diabetes Care 2018; 41: 1299–1311. |
| [20] | Besançon S, Beran D, Bouenizabila É. Access to insulin in developing countries: A complex issue. MmM. 2014; 8 (2): 153–7. |
| [21] | Gill G V. Stability of insulin in tropical countries. Trop Med Int Heal. 2000; 5 (9): 666–7. |
APA Style
Sitraka Angelo Raharinavalona, Rija Eric Raherison, Thierry Razanamparany, Solofo Andrianarivelo Ralamboson, Hanta Marie Danielle Vololontiana, et al. (2021). Insulin Availability and Affordability in the Urban Municipality of Antananarivo, Madagascar. International Journal of Diabetes and Endocrinology, 6(1), 1-4. https://doi.org/10.11648/j.ijde.20210601.11
ACS Style
Sitraka Angelo Raharinavalona; Rija Eric Raherison; Thierry Razanamparany; Solofo Andrianarivelo Ralamboson; Hanta Marie Danielle Vololontiana, et al. Insulin Availability and Affordability in the Urban Municipality of Antananarivo, Madagascar. Int. J. Diabetes Endocrinol. 2021, 6(1), 1-4. doi: 10.11648/j.ijde.20210601.11
AMA Style
Sitraka Angelo Raharinavalona, Rija Eric Raherison, Thierry Razanamparany, Solofo Andrianarivelo Ralamboson, Hanta Marie Danielle Vololontiana, et al. Insulin Availability and Affordability in the Urban Municipality of Antananarivo, Madagascar. Int J Diabetes Endocrinol. 2021;6(1):1-4. doi: 10.11648/j.ijde.20210601.11
Share This Article
Twitter
Linked In
Facebook
Copy
Download@article{10.11648/j.ijde.20210601.11,
author = {Sitraka Angelo Raharinavalona and Rija Eric Raherison and Thierry Razanamparany and Solofo Andrianarivelo Ralamboson and Hanta Marie Danielle Vololontiana and Andrinirina Dave Patrick Rakotomalala},
title = {Insulin Availability and Affordability in the Urban Municipality of Antananarivo, Madagascar},
journal = {International Journal of Diabetes and Endocrinology},
volume = {6},
number = {1},
pages = {1-4},
doi = {10.11648/j.ijde.20210601.11},
url = {https://doi.org/10.11648/j.ijde.20210601.11},
eprint = {https://article.sciencepublishinggroup.com/pdf/10.11648.j.ijde.20210601.11},
abstract = {Background: Insulin is classified as an "essential drug". It should be available in all pharmacies at an affordable price. This remains a major problem in low income countries like ours. Aim: Our study aims to describe the insulin availability and affordability in the Urban Municipality of Antananarivo, Madagascar. Methods: It was a cross sectional study over a period of 3 months at all pharmacies existing in the Urban Municipality of Antananarivo. Insulin availability was assessed according to the classification of the World Health Organization. Affordability was assessed from the ratio between the monthly cost of insulin treatment and the Malagasy monthly health expenditure, and the ratio between the monthly cost of insulin treatment and the guaranteed minimum inter-professional wage in Madagascar. Result: We had retained 79 pharmacies. Insulin availability in private pharmacies was higher than in public hospital pharmacies. Human insulin had a high availability rate: short-acting (70.89%) and mixed (78.08%). Availability of analogue insulin was low: fast-acting (7.59%) and long-acting (34.18%). To buy insulin, a patient was spending monthly 18.75 to 236.24% of the equivalent of guaranteed minimum inter-professional wage. All pharmacies had refrigerators to store insulin. Conclusion: The availability of insulin in the Urban Municipality of Antananarivo was high while diabetic patients have low financial affordability. A good governance health policy and multisectoral actions would be necessary.},
year = {2021}
}
TY - JOUR T1 - Insulin Availability and Affordability in the Urban Municipality of Antananarivo, Madagascar AU - Sitraka Angelo Raharinavalona AU - Rija Eric Raherison AU - Thierry Razanamparany AU - Solofo Andrianarivelo Ralamboson AU - Hanta Marie Danielle Vololontiana AU - Andrinirina Dave Patrick Rakotomalala Y1 - 2021/01/12 PY - 2021 N1 - https://doi.org/10.11648/j.ijde.20210601.11 DO - 10.11648/j.ijde.20210601.11 T2 - International Journal of Diabetes and Endocrinology JF - International Journal of Diabetes and Endocrinology JO - International Journal of Diabetes and Endocrinology SP - 1 EP - 4 PB - Science Publishing Group SN - 2640-1371 UR - https://doi.org/10.11648/j.ijde.20210601.11 AB - Background: Insulin is classified as an "essential drug". It should be available in all pharmacies at an affordable price. This remains a major problem in low income countries like ours. Aim: Our study aims to describe the insulin availability and affordability in the Urban Municipality of Antananarivo, Madagascar. Methods: It was a cross sectional study over a period of 3 months at all pharmacies existing in the Urban Municipality of Antananarivo. Insulin availability was assessed according to the classification of the World Health Organization. Affordability was assessed from the ratio between the monthly cost of insulin treatment and the Malagasy monthly health expenditure, and the ratio between the monthly cost of insulin treatment and the guaranteed minimum inter-professional wage in Madagascar. Result: We had retained 79 pharmacies. Insulin availability in private pharmacies was higher than in public hospital pharmacies. Human insulin had a high availability rate: short-acting (70.89%) and mixed (78.08%). Availability of analogue insulin was low: fast-acting (7.59%) and long-acting (34.18%). To buy insulin, a patient was spending monthly 18.75 to 236.24% of the equivalent of guaranteed minimum inter-professional wage. All pharmacies had refrigerators to store insulin. Conclusion: The availability of insulin in the Urban Municipality of Antananarivo was high while diabetic patients have low financial affordability. A good governance health policy and multisectoral actions would be necessary. VL - 6 IS - 1 ER -
Information
Email: